BDBM410615 (rac)-N-(5-(7-hydroxy-1,2,5,5a,6,7-hexahydro-4H-[1,4]oxazepino[4,5-a]quinolin-10-yl)-6-methylpyridin-3-yl)-2-(trifluoromethyl)isonicotinamide::US10377770, Example 441

SMILES Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1ccc2C(O)CC3CCOCCN3c2c1

InChI Key InChIKey=LVHFISKJEKNQOF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 410615   

TargetRAF proto-oncogene serine/threonine-protein kinase [Y340E,Y341E](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410615((rac)-N-(5-(7-hydroxy-1,2,5,5a,6,7-hexahydro-4H-[1...)
Affinity DataIC50: <0.100nMAssay Description:The activity of a compound according to the present invention can be assessed by well-known in vitro & in vivo methods. Raf inhibition data provided ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent